These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 16838338)
1. EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient. Janssens A; Berth M; De Paepe P; Verhasselt B; Van Roy N; Noens L; Philippé J; Offner F Am J Hematol; 2006 Sep; 81(9):706-12. PubMed ID: 16838338 [TBL] [Abstract][Full Text] [Related]
2. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine. Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847 [TBL] [Abstract][Full Text] [Related]
3. Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection. Rubin D; Hudnall SD; Aisenberg A; Jacobson JO; Harris NL Mod Pathol; 1994 Jan; 7(1):91-8. PubMed ID: 8159658 [TBL] [Abstract][Full Text] [Related]
4. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764 [TBL] [Abstract][Full Text] [Related]
5. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL. Tzankov A; Fong D Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567 [TBL] [Abstract][Full Text] [Related]
6. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. de Leval L; Vivario M; De Prijck B; Zhou Y; Boniver J; Harris NL; Isaacson P; Du MQ Am J Surg Pathol; 2004 May; 28(5):679-86. PubMed ID: 15105659 [TBL] [Abstract][Full Text] [Related]
7. Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome. Roch N; Salameire D; Gressin R; Morand P; Epaulard O; Pavese P; Brion JP; Stahl JP Scand J Infect Dis; 2008; 40(4):343-6. PubMed ID: 17934981 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection in Richter's transformation. Ansell SM; Li CY; Lloyd RV; Phyliky RL Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature. Duong T; Grange F; Auffret N; Aractingi S; Bodemer C; Brousse N; Hermine O; Fraitag S Dermatology; 2010; 220(3):226-33. PubMed ID: 20145381 [TBL] [Abstract][Full Text] [Related]
10. Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia. Sohani AR; Ferry JA; Chang PS; Abramson JS J Clin Oncol; 2010 Feb; 28(5):e69-72. PubMed ID: 19917859 [No Abstract] [Full Text] [Related]
12. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation. Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277 [TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning? Hale G; Slavin S; Goldman JM; Mackinnon S; Giralt S; Waldmann H Bone Marrow Transplant; 2002 Dec; 30(12):797-804. PubMed ID: 12476271 [TBL] [Abstract][Full Text] [Related]
15. Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. Moreton P; Kennedy B; Lucas G; Leach M; Rassam SM; Haynes A; Tighe J; Oscier D; Fegan C; Rawstron A; Hillmen P J Clin Oncol; 2005 May; 23(13):2971-9. PubMed ID: 15738539 [TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia. O'Brien SM; Kantarjian HM; Thomas DA; Cortes J; Giles FJ; Wierda WG; Koller CA; Ferrajoli A; Browning M; Lerner S; Albitar M; Keating MJ Cancer; 2003 Dec; 98(12):2657-63. PubMed ID: 14669286 [TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. Montillo M; Tedeschi A; Miqueleiz S; Veronese S; Cairoli R; Intropido L; Ricci F; Colosimo A; Scarpati B; Montagna M; Nichelatti M; Regazzi M; Morra E J Clin Oncol; 2006 May; 24(15):2337-42. PubMed ID: 16618945 [TBL] [Abstract][Full Text] [Related]
19. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome. Matolcsy A; Casali P; Knowles DM Ann N Y Acad Sci; 1995 Sep; 764():496-503. PubMed ID: 7486574 [TBL] [Abstract][Full Text] [Related]
20. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Timár B; Fülöp Z; Csernus B; Angster C; Bognár A; Szepesi A; Kopper L; Matolcsy A Leukemia; 2004 Feb; 18(2):326-30. PubMed ID: 14671632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]